Curanex Pharmaceuticals Announces 1-for-20 Reverse Stock Split

What happened

Curanex Pharmaceuticals Inc., a Nevada-based pharmaceutical company listed on the Nasdaq Capital Market under the ticker CURX, announced a 1-for-20 reverse stock split. The company filed a Certificate of Amendment with the Nevada Secretary of State on August 14, 2026, which will take effect at 12:01 a.m. Pacific Time on August 20, 2026.

The split means that every 20 shares of common stock will automatically convert into one share. Based on the 31,364,812 shares outstanding before the split, the company expects to have approximately 1,568,241 shares outstanding after the split. No fractional shares will be issued; instead, any fractional shares will be rounded up to the nearest whole share.

The company's stock price jumped dramatically following the announcement, with the closing price on August 17, 2026, at $5.30, up from the previous close of $0.2057, a change of over 2,400%.

Why it happened

According to the filing, the purpose of the reverse stock split is to regain compliance with the $1.00 minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2). The company's stock had been trading below that threshold, risking delisting from the exchange.

The board of directors had approved the split in July 2026, after receiving shareholder approval in June 2026. The board had discretion to choose a ratio between 1-for-10 and 1-for-50, and selected 1-for-20.

What this means

A reverse stock split is a corporate action that reduces the number of outstanding shares while increasing the price per share proportionally. It does not change the total value of a shareholder's investment (before market reactions), but it can help a company meet exchange listing requirements like the minimum bid price.

The filing is an 8-K, which companies use to disclose unscheduled material events. Item 5.03 covers amendments to articles of incorporation or bylaws, and Item 3.03 covers material modifications to security holder rights. This filing tells shareholders and the market about the upcoming split and its mechanics.

After the effective date, the stock will trade on a split-adjusted basis under the same ticker 'CURX' but with a new CUSIP number. The company's transfer agent, VStock Transfer, LLC, will handle the exchange of shares and provide instructions to stockholders of record.